Patterns and outcomes of paracetamol poisoning management in Hamad Medical Corporation, Qatar: A retrospective cohort study
- PMID: 37746996
- PMCID: PMC10519564
- DOI: 10.1097/MD.0000000000034872
Patterns and outcomes of paracetamol poisoning management in Hamad Medical Corporation, Qatar: A retrospective cohort study
Abstract
We aimed to investigate the characteristics and clinical outcomes of paracetamol poisoning and paracetamol overdose in Qatar. This retrospective cohort study included patients admitted to the emergency department (ED). We included patients who presented with excessive paracetamol ingestion, between December 2018 and September 2019. The primary outcomes were describing the characteristics and outcomes of paracetamol overdose (from a suicidal overdose or accidental overdose, dose ≤ 150 mg/kg, when serum levels of <60 mmol/L) or dose ingested (≤75 mg/kg) with staggered ingestion poisoning due to suicidal attempt or accidental attempt, defined as the dose ingested (>150 mg/kg), acute ingestion, nomogram level more than the treatment line, or dose ingested (>75 mg/kg) with staggered ingestion, and assessing the management of excessive paracetamol ingestion. Secondary outcomes included evaluation of the time difference between ingestion and time of administration, hospitalization, and adverse drug events. Significant differences were detected between patients who presented with paracetamol overdose and those who presented with paracetamol toxicity. A total of 69 patients were analyzed, of whom 43 received paracetamol overdose (mean age 27.5 ± 11.1 years) and 26 had paracetamol poisoning (mean age 25 ± 6.22 years). Paracetamol poisoning was identified in 26% of the patients with a 24.3% history of psychiatric illness, compared to 18.6% with paracetamol overdose. More patients presented with paracetamol toxicity in the time between ingestion and obtaining serum levels compared to the overdose group. A significantly longer length of hospitalization was observed in the toxicity group. A significantly higher number of patients in the toxicity group received N-acetylcysteine (NAC). More hypotension and rashes were observed among those who received NAC in the toxicity group. Patients presenting to the ED due to paracetamol toxicity are not uncommon, and most cases occur in young adults, and few in patients with a history of psychiatric illness, suggesting that preventive approaches are highly required.
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series.Emerg Med Australas. 2014 Aug;26(4):398-402. doi: 10.1111/1742-6723.12249. Epub 2014 Jun 17. Emerg Med Australas. 2014. PMID: 24934700
-
A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning.Clin Toxicol (Phila). 2016;54(2):120-6. doi: 10.3109/15563650.2015.1115057. Epub 2015 Dec 22. Clin Toxicol (Phila). 2016. PMID: 26691690
-
Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose.Clin Toxicol (Phila). 2013 Sep-Oct;51(8):772-6. doi: 10.3109/15563650.2013.830733. Epub 2013 Aug 22. Clin Toxicol (Phila). 2013. PMID: 23964853 Free PMC article.
-
Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand.Med J Aust. 2020 Mar;212(4):175-183. doi: 10.5694/mja2.50428. Epub 2019 Dec 1. Med J Aust. 2020. PMID: 31786822 Review.
-
Paracetamol poisoning: beyond the nomogram.Br J Clin Pharmacol. 2015 Jul;80(1):45-50. doi: 10.1111/bcp.12604. Epub 2015 Jun 1. Br J Clin Pharmacol. 2015. PMID: 26099917 Free PMC article. Review.
Cited by
-
Natural Products That Protect Against Acetaminophen Hepatotoxicity: A Call for Increased Rigor in Preclinical Studies of Dietary Supplements.J Diet Suppl. 2025;22(1):105-122. doi: 10.1080/19390211.2024.2335573. Epub 2024 Apr 1. J Diet Suppl. 2025. PMID: 38562009 Review.
References
-
- Gummin DD, Mowry JB, Spyker DA, et al. . 2017 Annual report of the american association of poison control centers’ National Poison Data System (NPDS): 35th annual report. Clin Toxicol. 2018;56:1213–415. - PubMed
-
- Friedman N, Shoshani-Levy M, Brent J, et al. . Fatalities in poisoned patients managed by medical toxicologists. Clin Toxicol. 2019;58:688–91. - PubMed
-
- Bateman DN, Dear JW, Thanacoody HKR, et al. . Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet. 2014;383:697–704. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical